USPTO trademark

HYBRID SHADOW ADJUDICATION

AllowedUSPTOWord markClass 42

"HYBRID SHADOW ADJUDICATION" is a word mark owned by Prime Therapeutics LLC, filed at the USPTO on November 3, 2025. It has been allowed and covers class 42 (Computer and Scientific Services).

View Prime Therapeutics LLC portfolioGet this data via the API
Official USPTO record
HYBRID SHADOW ADJUDICATION trademark as filed
As filed with the USPTO
Status
Allowed
Since June 16, 2026
Filed
November 3, 2025
Registered
Not yet
Expires
Not recorded
Application no.
99476483
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns HYBRID SHADOW ADJUDICATION

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Prime Therapeutics LLC

Eagan, United States

45 trademarks in the portfolioView company

Representative

Felicia J. Boyd

Norton Rose Fulbright US LLP

Goods and services

What the mark covers

The products and services HYBRID SHADOW ADJUDICATION is filed for, grouped by Nice class.

  • Platform as a Service (PAAS) featuring computer software platforms for providing comparisons of data and information from legacy software systems to new software systems to assist in data migration, data integration, business implementations, data configuration, and to identify and resolve issues to minimize post-implementation disruptions in the field of medical clinical trials, medical and prescription drug benefits, utilization and coverage

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Noa e-mailed - sou required from applicant
  2. Official gazette publication confirmation e-mailed
  3. Published for opposition
  4. Notification of notice of publication e-mailed
  5. Approved for pub - principal register
  6. Examiner's amendment entered
  7. Notification of examiners amendment e-mailed
  8. Examiners amendment e-mailed
  9. Examiners amendment -written
  10. Notification of non-final action e-mailed

6 earlier steps on the official record.

FAQ

About HYBRID SHADOW ADJUDICATION

Who owns the trademark "HYBRID SHADOW ADJUDICATION"?

The USPTO trademark "HYBRID SHADOW ADJUDICATION" (application 99476483) is owned by Prime Therapeutics LLC.

What is the status of "HYBRID SHADOW ADJUDICATION"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull HYBRID SHADOW ADJUDICATION and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2b54-91e5-740c-84bd-d8eea51d19d9
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b54-91e5-740c-84bd-d8eea51d19d9",
  "object": "trademark",
  "mark_text": "HYBRID SHADOW ADJUDICATION",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99476483",
  "filing_date": "2025-11-03",
  "nice_classes": [
    42
  ],
  "owners": [
    {
      "name": "Prime Therapeutics LLC",
      "entity_id": "ent_019eb6fe-75bc-7498-b91a-6bffe9e5b38d"
    }
  ]
}